EMD-30915
Apo spike protein of SARS-CoV2
EMD-30915
Single-particle3.45 Å
Deposition: 22/01/2021Map released: 02/06/2021
Last modified: 07/07/2021
Sample Organism:
Severe acute respiratory syndrome coronavirus 2
Sample: Apo spike protein trimer of SARS-CoV2
Fitted models: 7dzw
Deposition Authors: Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
Sample: Apo spike protein trimer of SARS-CoV2
Fitted models: 7dzw
Deposition Authors: Liu Y, Soh WT, Kishikawa J, Hirose M, Kato T, Okada M, Arase H
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
Liu Y
,
Soh WT
,
Kishikawa JI
,
Hirose M
,
Nakayama EE,
Li S
,
Sasai M
,
Suzuki T,
Tada A,
Arakawa A,
Matsuoka S,
Akamatsu K,
Matsuda M,
Ono C,
Torii S
,
Kishida K,
Jin H,
Nakai W,
Arase N,
Nakagawa A,
Matsumoto M,
Nakazaki Y,
Shindo Y,
Kohyama M,
Tomii K,
Ohmura K,
Ohshima S,
Okamoto T,
Yamamoto M,
Nakagami H,
Matsuura Y,
Nakagawa A,
Kato T,
Okada M,
Standley DM,
Shioda T,
Arase H
(2021) Cell , 184 , 3452 - 3466.e18
,
Soh WT
,
Kishikawa JI
,
Hirose M
,
Nakayama EE,
Li S
,
Sasai M
,
Suzuki T,
Tada A,
Arakawa A,
Matsuoka S,
Akamatsu K,
Matsuda M,
Ono C,
Torii S
,
Kishida K,
Jin H,
Nakai W,
Arase N,
Nakagawa A,
Matsumoto M,
Nakazaki Y,
Shindo Y,
Kohyama M,
Tomii K,
Ohmura K,
Ohshima S,
Okamoto T,
Yamamoto M,
Nakagami H,
Matsuura Y,
Nakagawa A,
Kato T,
Okada M,
Standley DM,
Shioda T,
Arase H
(2021) Cell , 184 , 3452 - 3466.e18
Grant Support:
- Japan Agency for Medical Research and Development (AMED): JP19fk0108161 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP20nf0101623 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP20nk0101602 (Japan)
- Japan Agency for Medical Research and Development (AMED): JP17am0101108 (Japan)
- Ministry of Education, Culture, Sports, Science and Technology (Japan): JP19H04808 (Japan)
- Japan Society for the Promotion of Science (JSPS): JP18H05279 (Japan)
- Japan Society for the Promotion of Science (JSPS): JP19H03478 (Japan)
